Cancer and venous thromboembolism
Top Cited Papers
- 1 June 2005
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 6 (6) , 401-410
- https://doi.org/10.1016/s1470-2045(05)70207-2
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With CancerJournal of Clinical Oncology, 2005
- Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer PatientsJournal of Clinical Oncology, 2005
- TamoxifenCirculation, 2005
- A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast CancerNew England Journal of Medicine, 2004
- Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulationJournal of Thrombosis and Haemostasis, 2003
- Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosisBlood, 2002
- Efficacy and safety of enoxaparinversus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessmentBritish Journal of Surgery, 1997
- Cancer and venous thromboembolismAmerican Heart Journal, 1996
- Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerThe Lancet, 1994
- Fibrinolysis and CancerSeminars in Thrombosis and Hemostasis, 1990